Atara Biotherapeutics, Inc. · NASDAQ:ATRA
Panacea Innovation Ltd sold 313,446 Atara Biotherapeutics, Inc. shares (Form 4)
Traded May 7, 2026 · Filed May 11, 2026
On May 7, 2026, Panacea Innovation Ltd (10% owner) sold 313,446 Atara Biotherapeutics, Inc. shares at US$10.10 for US$3.17M, leaving 1,011,000 shares. Filed May 11, 2026 (Form 4).
- Sold
- 313,446 shares
- Price
- US$10.10
- Value
- US$3.17M
- Holding after
- 1,011,000 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | Sale | 313,446 | US$10.10 | 1,011,000 | Indirect |
Source
Related
- Atara Biotherapeutics, Inc.
- Panacea Innovation Ltd
- Atara Biotherapeutics, Inc. shareholders
- Form 4 · Cherry Brian N · Sep 4, 2026
- Form 4 · Nguyen AnhCo · Aug 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Redmile Group, LLC · Jul 24, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 24, 2026